Special Types of Thyroid Carcinoma

Overview

Journal Histopathology

Specialties Anatomy & Histology
Pathology

Date 2017 Dec 15

PMID 29239042

Citations 51

Authors

Zubair W Baloch

Virginia A LiVolsi

Affiliations

Soon will be listed here.

Abstract

This article reviews the small percentage of thyroid tumours that are not classified as classic papillary thyroid carcinoma, follicular thyroid carcinoma, and medullary thyroid carcinoma. It includes subtypes of papillary thyroid carcinoma, including, tall-cell, hobnail/micropapillary, columnar cell, diffuse sclerosing and solid variants. Poorly differentiated carcinoma, high-grade carcinoma and anaplastic thyroid carcinoma are reviewed. Also discussed are entities that are unusual but need to be recognized as primary thyroid neoplasms, i.e. mucoepidermoid carcinoma, sclerosing mucoepidermoid carcinoma with eosinophilia, and mammary analogue secretory carcinoma/secretory carcinoma. The pathological features and prognostic factors are described; a brief review of molecular correlates of these neoplasms is included.

Citing Articles

Sclerosing mucoepidermoid carcinoma of the thyroid with eosinophilia: a case report and review of the literature.

Han Q, Xu H J Med Case Rep. 2025; 19(1):84.

PMID: 40022195 PMC: 11871826. DOI: 10.1186/s13256-025-05096-3.

EFFICACY AND PROGNOSIS IN PATIENTS WITH PAPILLARY THYROID CANCER WITH POSTOPERATIVE PREABLATIVE STIMULATED THYROGLOBULIN ABOVE 10 NG/ML AFTER INITIAL THERAPY WITH RADIOIODINE.

Luo L, Xia J, Zhang R, Yao X Acta Endocrinol (Buchar). 2025; 20(2):186-192.

PMID: 39845749 PMC: 11750234. DOI: 10.4183/aeb.2024.186.

Aggressive variants of papillary thyroid carcinoma: characteristics, influencing factors, and effectiveness of radioiodine therapy.

Deng Y, Pan L, Xu Y, Duan Y, Chen E, Luo Y J Endocrinol Invest. 2024; .

PMID: 39652145 DOI: 10.1007/s40618-024-02507-y.

Sclerosing mucoepidermoid carcinoma of salivary glands.

Othman B, Bradova M, Simpson R, Laco J, Agaimy A, Rito M Virchows Arch. 2024; .

PMID: 39537991 DOI: 10.1007/s00428-024-03970-x.

RAI therapy in low-risk papillary thyroid cancer: recurrence reduction and long-term outcomes in the Turkish population.

Bilgic S, Meral R, Sager M, Sonmezoglu K BMC Cancer. 2024; 24(1):1273.

PMID: 39402494 PMC: 11475254. DOI: 10.1186/s12885-024-12986-0.